Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
CTH-301: An Open-Label, Phase 3 Study Examining the Long-Term Safety, Tolerability and Efficacy of APL-130277 in Levodopa Responsive Patients with Parkinson#s Disease Complicated by Motor Fluctuations (#OFF# Episodes)
Slevin, John
(PI)
Neuroscience Research Priority Area
Neurology
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
5/4/17
→
1/12/21
Funding
Sunovion Pharmaceuticals Incorporated:
$99,866.00
View all
View less